{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:26:08Z","timestamp":1783427168523,"version":"3.54.6"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00775-018-1606-0","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T07:07:11Z","timestamp":1535180831000},"page":"1227-1241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Aroylhydrazones constitute a promising class of \u2018metal-protein attenuating compounds\u2019 for the treatment of Alzheimer\u2019s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone"],"prefix":"10.1007","volume":"23","author":[{"given":"Daphne S.","family":"Cukierman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Accardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Garrido","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco C.","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Clara Ramalho","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Lanznaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio O.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"issue":"5054","key":"1606_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185","journal-title":"Science"},{"issue":"45","key":"1606_CR2","doi-asserted-by":"publisher","first-page":"46363","DOI":"10.1074\/jbc.C400260200","volume":"279","author":"R Kayed","year":"2004","unstructured":"Kayed R et al (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279(45):46363\u201346366","journal-title":"J Biol Chem"},{"issue":"4","key":"1606_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","volume":"24","author":"WL Klein","year":"2001","unstructured":"Klein WL, Krafft GA, Finch CE (2001) Targeting small Abeta oligomers: the solution to an Alzheimer\u2019s disease conundrum? Trends Neurosci 24(4):219\u2013224","journal-title":"Trends Neurosci"},{"issue":"11","key":"1606_CR4","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95(11):6448\u20136453","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1606_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/biom4010101","volume":"4","author":"F Hane","year":"2014","unstructured":"Hane F, Leonenko Z (2014) Effect of metals on kinetic pathways of amyloid-\u03b2 aggregation. Biomolecules 4(1):101\u2013116","journal-title":"Biomolecules"},{"issue":"3","key":"1606_CR6","doi-asserted-by":"publisher","first-page":"e59005","DOI":"10.1371\/journal.pone.0059005","volume":"8","author":"F Hane","year":"2013","unstructured":"Hane F et al (2013) Cu(2+) affects amyloid-\u03b2 (1\u201342) aggregation by increasing peptide-peptide binding forces. PLoS One 8(3):e59005","journal-title":"PLoS One"},{"issue":"1\u20132","key":"1606_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","volume":"143","author":"MA Deibel","year":"1996","unstructured":"Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer\u2019s disease: possible relation to oxidative stress. J Neurol Sci 143(1\u20132):137\u2013142","journal-title":"J Neurol Sci"},{"key":"1606_CR8","doi-asserted-by":"crossref","first-page":"539762","DOI":"10.4061\/2011\/539762","volume":"2011","author":"S Azimi","year":"2011","unstructured":"Azimi S, Rauk A (2011) On the involvement of copper binding to the N terminus of the amyloid Beta Peptide of Alzheimer\u2019s disease: a computational study on model systems. Int J Alzheimers Dis 2011:539762","journal-title":"Int J Alzheimers Dis"},{"issue":"5","key":"1606_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/j.1471-4159.2007.05061.x","volume":"104","author":"V T\u00f5ugu","year":"2008","unstructured":"T\u00f5ugu V, Karafin A, Palumaa P (2008) Binding of zinc(II) and copper(II) to the full-length Alzheimer\u2019s amyloid-beta peptide. J Neurochem 104(5):1249\u20131259","journal-title":"J Neurochem"},{"issue":"8","key":"1606_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00775-004-0602-8","volume":"9","author":"X Huang","year":"2004","unstructured":"Huang X et al (2004) Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer\u2019s Abeta peptides. J Biol Inorg Chem 9(8):954\u2013960","journal-title":"J Biol Inorg Chem"},{"issue":"3","key":"1606_CR11","doi-asserted-by":"publisher","first-page":"e33552","DOI":"10.1371\/journal.pone.0033552","volume":"7","author":"TJ Craddock","year":"2012","unstructured":"Craddock TJ et al (2012) The zinc dyshomeostasis hypothesis of Alzheimer\u2019s disease. PLoS One 7(3):e33552","journal-title":"PLoS One"},{"key":"1606_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1039\/B813398K","volume":"7","author":"P Faller","year":"2009","unstructured":"Faller P, Hureau C (2009) Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans 7:1080\u20131094","journal-title":"Dalton Trans"},{"issue":"23","key":"1606_CR13","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1021\/bi0002479","volume":"39","author":"T Miura","year":"2000","unstructured":"Miura T et al (2000) Metal binding modes of Alzheimer\u2019s amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 39(23):7024\u20137031","journal-title":"Biochemistry"},{"issue":"22","key":"1606_CR14","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1046\/j.1432-1327.2000.01767.x","volume":"267","author":"DS Yang","year":"2000","unstructured":"Yang DS et al (2000) Examining the zinc binding site of the amyloid-beta peptide. Eur J Biochem 267(22):6692\u20136698","journal-title":"Eur J Biochem"},{"issue":"50","key":"1606_CR15","doi-asserted-by":"publisher","first-page":"15910","DOI":"10.1002\/chem.201202697","volume":"18","author":"P Faller","year":"2012","unstructured":"Faller P, Hureau C (2012) A bioinorganic view of Alzheimer\u2019s disease: when misplaced metal ions (re)direct the electrons to the wrong target. Chemistry 18(50):15910\u201315920","journal-title":"Chemistry"},{"issue":"1","key":"1606_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141296","volume":"46","author":"M Ventriglia","year":"2015","unstructured":"Ventriglia M et al (2015) Zinc in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 46(1):75\u201387","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1606_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JAD-2010-101473","volume":"24","author":"S Bucossi","year":"2011","unstructured":"Bucossi S et al (2011) Copper in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 24(1):175\u2013185","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"1606_CR18","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1021\/cr9000176","volume":"109","author":"LE Scott","year":"2009","unstructured":"Scott LE, Orvig C (2009) Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev 109(10):4885\u20134910","journal-title":"Chem Rev"},{"issue":"3","key":"1606_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.bmc.2010.12.007","volume":"19","author":"A Gaeta","year":"2011","unstructured":"Gaeta A et al (2011) Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: iron chelators with the potential for treating Alzheimer\u2019s disease. Bioorg Med Chem 19(3):1285\u20131297","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"1606_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/v10007-011-0006-6","volume":"61","author":"A Budimir","year":"2011","unstructured":"Budimir A (2011) Metal ions, Alzheimer\u2019s disease and chelation therapy. Acta Pharm 61(1):1\u201314","journal-title":"Acta Pharm"},{"issue":"3","key":"1606_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30(3):665\u2013676","journal-title":"Neuron"},{"key":"1606_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fnins.2017.00317","volume":"11","author":"SC Drew","year":"2017","unstructured":"Drew SC (2017) The case for abandoning therapeutic chelation of copper ions in Alzheimer\u2019s disease. Front Neurosci 11:317","journal-title":"Front Neurosci"},{"key":"1606_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fneur.2017.00503","volume":"8","author":"R Squitti","year":"2017","unstructured":"Squitti R et al (2017) Commentary: the case for abandoning therapeutic chelation of copper ions in Alzheimer\u2019s disease. Front Neurol 8:503","journal-title":"Front Neurol"},{"key":"1606_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.saa.2013.06.105","volume":"116","author":"LV Freitas de","year":"2013","unstructured":"de Freitas LV et al (2013) Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone\u2014a potential metal-protein attenuating compound (MPAC) for the treatment of Alzheimer\u2019s disease. Spectrochim Acta A Mol Biomol Spectrosc 116:41\u201348","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"1606_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1039\/C5MT00003C","volume":"7","author":"RA Hauser-Davis","year":"2015","unstructured":"Hauser-Davis RA et al (2015) Disruption of zinc and copper interactions with A\u03b2(1\u201340) by a non-toxic, isoniazid-derived, hydrazone: a novel biometal homeostasis restoring agent in Alzheimer\u2019s disease therapy? Metallomics 7:743\u2013747","journal-title":"Metallomics"},{"key":"1606_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jinorgbio.2017.02.020","volume":"170","author":"DS Cukierman","year":"2017","unstructured":"Cukierman DS et al (2017) A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson\u2019s disease: therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. J Inorg Biochem 170:160\u2013168","journal-title":"J Inorg Biochem"},{"issue":"5","key":"1606_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0022-2143(99)90173-7","volume":"134","author":"E Becker","year":"1999","unstructured":"Becker E, Richardson DR (1999) Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs. J Lab Clin Med 134(5):510\u2013521","journal-title":"J Lab Clin Med"},{"issue":"6","key":"1606_CR28","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ejic.200390146","volume":"2003","author":"Claire M Armstrong","year":"2003","unstructured":"Armstrong Claire M et al (2003) Structural variations and formation constants of first-row transition metal complexes of biologically active aroylhydrazones. Eur J Inorg Chem 2003(6):1145\u20131156","journal-title":"Eur J Inorg Chem"},{"key":"1606_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ica.2012.12.018","volume":"398","author":"S Mondal","year":"2013","unstructured":"Mondal S, Naskar S, Deya AK, Sinn E, Eribalb C, Herronc SR, Chattopadhyaya SK (2013) Mononuclear and binuclear Cu(II) complexes of some tridentate aroyl hydrazones. X-ray crystal structures of a mononuclear and a binuclear complex. Inorg Chim Acta 398:98\u2013105","journal-title":"Inorg Chim Acta"},{"key":"1606_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ica.2014.11.028","volume":"427","author":"AA Khandar","year":"2015","unstructured":"Khandar AA, Afkhami FA, Hosseini-Yazdi SA, White JM, Kassel S, Dougherty WG, Lipkowski J, Van Derveer D, Giester G, Costantino F (2015) Anion influence in the structural diversity of cadmium coordination polymers constructed from a pyridine based Schiff base ligand. Inorg Chim Acta 427:87\u201396","journal-title":"Inorg Chim Acta"},{"key":"1606_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.molstruc.2016.01.051","volume":"1110","author":"L Li","year":"2016","unstructured":"Li L, Zhang YZ, Liu E, Yang C, Golen JA, Rheingold AL, Zhang G (2016) Synthesis and structural characterization of zinc(II) and cobalt(II) complexes based on multidentate hydrazone ligands. J Mol Struct 1110:180\u2013184","journal-title":"J Mol Struct"},{"issue":"6","key":"1606_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000051288","volume":"12","author":"B Regland","year":"2001","unstructured":"Regland B et al (2001) Treatment of Alzheimer\u2019s disease with clioquinol. Dement Geriatr Cogn Disord 12(6):408\u2013414","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1606_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","volume":"59","author":"PA Adlard","year":"2008","unstructured":"Adlard PA et al (2008) Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59(1):43\u201355","journal-title":"Neuron"},{"issue":"1","key":"1606_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1471-4159.2005.03340.x","volume":"95","author":"H Zheng","year":"2005","unstructured":"Zheng H et al (2005) Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. J Neurochem 95(1):68\u201378","journal-title":"J Neurochem"},{"key":"1606_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jinorgbio.2014.04.011","volume":"139","author":"LM Gomes","year":"2014","unstructured":"Gomes LM et al (2014) 8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated A\u03b2 peptide aggregation. J Inorg Biochem 139:106\u2013116","journal-title":"J Inorg Biochem"},{"key":"1606_CR36","unstructured":"Richardson D, Bernhardt PV, Becker EM (2006) Iron chelators and uses thereof. US6989397 B1"},{"key":"1606_CR37","unstructured":"Bruker (2004) APEX2 user manual. Version 1.22 ed"},{"key":"1606_CR38","volume-title":"SAINT Integration Software","author":"Bruker","year":"1999","unstructured":"Bruker (1999) SAINT Integration Software. Bruker AXS Inc., Madison"},{"issue":"Pt 1","key":"1606_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053229614024218","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick GM (2015) Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem 71(Pt 1):3\u20138","journal-title":"Acta Crystallogr C Struct Chem"},{"issue":"Pt 1","key":"1606_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"GM Sheldrick","year":"2008","unstructured":"Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A 64(Pt 1):112\u2013122","journal-title":"Acta Crystallogr A"},{"key":"1606_CR41","unstructured":"International Tables for Crystallography C (2006)"},{"issue":"2","key":"1606_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1107\/S0021889808042726","volume":"42","author":"Dolomanov","year":"2009","unstructured":"Dolomanov et al (2009) OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr 42(2):339\u2013341","journal-title":"J Appl Crystallogr"},{"key":"1606_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0371-1951(64)80040-0","volume":"20","author":"I Nakacjawa","year":"1964","unstructured":"Nakacjawa I, Shimanouchi T (1964) Infrared absorption spectra of aquo complexes and the nature of co-ordination bands. Spectrochim Acta 20:429\u2013439","journal-title":"Spectrochim Acta"},{"key":"1606_CR44","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/0584-8539(70)80179-9","volume":"26","author":"D Bryson","year":"1970","unstructured":"Bryson D, Nuttall RH (1970) The far infrared spectra of five co-ordinate complexes. Spectrochim Acta Part A 26:2275\u20132280","journal-title":"Spectrochim Acta Part A"},{"key":"1606_CR45","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1021\/ic50038a026","volume":"5","author":"CW Frank","year":"1966","unstructured":"Frank CW, Rogers LB (1966) Infrared Spectral study of metal-pyridine, -substituted pyridine, and -quinoline complexes in the 667\u2013150\u00a0cm\u22121 Region. Inorg Chem 5:615\u2013622","journal-title":"Inorg Chem"},{"key":"1606_CR46","doi-asserted-by":"publisher","first-page":"10742","DOI":"10.1039\/c1dt11000d","volume":"40","author":"R D\u00edaz-Torres","year":"2011","unstructured":"D\u00edaz-Torres R, Coordinating AS (2011) Ability of anions and solvents towards transition metals and lanthanides. Dalton Trans 40:10742\u201310750","journal-title":"Dalton Trans"},{"key":"1606_CR47","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1039\/b704102k","volume":"30","author":"PV Bernhardt","year":"2007","unstructured":"Bernhardt PV et al (2007) Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity. Dalton Trans 30:3232\u20133244","journal-title":"Dalton Trans"},{"issue":"3","key":"1606_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","volume":"5","author":"AI Bush","year":"2008","unstructured":"Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer\u2019s disease based on the metal hypothesis. Neurotherapeutics 5(3):421\u2013432","journal-title":"Neurotherapeutics"},{"issue":"47","key":"1606_CR49","doi-asserted-by":"publisher","first-page":"13658","DOI":"10.1021\/bi701355j","volume":"46","author":"C Talmard","year":"2007","unstructured":"Talmard C, Bouzan A, Faller P (2007) Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors. Biochemistry 46(47):13658\u201313666","journal-title":"Biochemistry"},{"issue":"4","key":"1606_CR50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","volume":"2","author":"H Pajouhesh","year":"2005","unstructured":"Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2(4):541\u2013553","journal-title":"NeuroRx"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00775-018-1606-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-018-1606-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-018-1606-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T16:10:27Z","timestamp":1720541427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00775-018-1606-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1007\/s00775-018-1606-0","relation":{},"ISSN":["0949-8257","1432-1327"],"issn-type":[{"value":"0949-8257","type":"print"},{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"18 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}